KY
Krishna Yeshwant

Krishna Yeshwant insider trades: Verve Therapeutics (VERV) stock buys and sales

Verve Therapeutics Last trade Dec 1, 2023 25 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2014
4
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Krishna reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 1, 2023VERV↑ Buy$18.0M
Nov 4, 2022VERV↓ Sell$1.5M
Nov 3, 2022VERV↓ Sell$2.7M
Nov 1, 2022VERV↓ Sell$3.3M
Aug 8, 2017FMI↓ Sell$192K
Aug 4, 2017FMI↓ Sell$666K
Jun 15, 2015FMI↓ Sell$6.1M
May 14, 2015FMI↓ Sell$332K
Jun 13, 2014FMI↓ Sell$29.1M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Krishna Yeshwant's insider trades

Krishna Yeshwant is an insider at Verve Therapeutics (VERV). Since Jun 13, 2014, Krishna has reported 1 open-market purchase worth $18.0M and 8 sales worth $43.8M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (10 filings), other transactions (6 filings), shares returned to the company (2 filings), conversions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VERV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.